The VEGF–VEGFR2–NRP1-mediated signaling in GSCs is maintained in an autocrine manner via the continuous secretion of VEGF, allowing for the persistent activation of downstream intracellular pro-survival pathways and promoting tumor growth and resistance to some treatments [79]. This evidence concerns the gene VEGFA and neoplasm.